Page 392 - Company News

Airtel signs deal with Elon Musk's SpaceX to bring Starlink to India

Airtel will distribute Starlink's equipment at its retail stores, sell Starlink services to business customers

US' Glas Trust moves NCLAT for stay over amendments in Aakash's AoA

The Chennai bench of the National Company Law Appellate Tribunal will hear the matter next week

Godrej Agrovet to acquire 48% stake in Creamline Dairy for Rs 930 cr

Creamline Dairy Products will become a wholly owned subsidiary of Godrej Agrovet upon completion of the deal

PhonePe clocks 600 mn registered users, adds 100 mn in past 16 months

The company claims to have a base of over 40 million merchants. It processes over 330 million transactions daily and has recorded an annualized total payment value of over Rs 150 trillion

Adani Group wins Rs 36,000 cr Mumbai's Motilal Nagar redevelopment project

In Dharavi Redevelopment Project Pvt Ltd (now called Navbharat Mega Developers Pvt Ltd), Adani Group held an 80 per cent stake while the rest was with the state government

Zydus Lifesciences to buy 86% stake in Amplitude Surgical for Rs 2,430 cr

Zydus will file a mandatory cash tender offer for the remaining shares of Amplitude at the same purchase price of €6.25 per share

PB Fintech to infuse Rs 696 crore in arm PB Healthcare Services in FY26

The board approved a proposal to make an investment for an aggregate amount of up to Rs 696 crore in PB Healthcare Services Private Limited

Musk's Starlink to vie with Indian telcos in fixed wireless access space

The challenge of course for Starlink will be to price its product competitively against both Jio as well as Airtel in FWA and with Airtel in satellite broadband

Former RBI deputy governor MK Jain to join Reliance Industries as advisor

The appointment comes at a time when other business conglomerates, including the Tatas, are investing heavily in the financial services sector

IndusInd Bank CEO confident of Q4 net profit despite derivatives hit

Kathpalia assures strong capital adequacy as promoters reaffirm trust in bank

TCS to acquire Darshita Southern India Happy Homes for Rs 2,250 crore

The acquisition is focused on acquiring the land and building of Darshita to expand TCS's delivery centre

India to be in our top three growth regions by 2028: Danfoss India prez

Currently, the Indian subsidiary has moved into the top six in Danfoss' global rankings, recording strong double-digit growth in 2024, Danfoss India President Ravichandran Purushothaman said

Roadstar InvIT may onboard strategic partner to acquire large road assets

The InvIT wants to keep all options open, with acquisitions purely based on value. However, it may preferably target assets from the NHAI

Raptee launches electric motorcycle with 4-wheeler charging compatibility

The company expects to reach $25 million in first-year sales, supported by growing demand for premium electric motorcycles and increasing availability of fast-charging options

Sakthi, Diamond form joint venture to manufacture trainer aircraft in Hisar

As part of this arrangement, Sakthi will manufacture 200 aircraft exclusively for ACI

Yamaha Motor launches its first hybrid motorcycle in India's 150cc segment

Yamaha has not disclosed official mileage figures but claims that the hybrid variant will deliver better fuel efficiency than the petrol-only FZ-S

CCI clears ONGC-NTPC Green's proposal to acquire Ayana for Rs 19,500 cr

Ayana, a leading renewable energy platform, has about 4.1 GW of operational and under-construction assets, strategically located across resource-rich states

Tata Technologies announces leadership changes to drive growth strategy

The changes are part of the company's 'One Team with Customers' philosophy by deepening integration with top global clients through dedicated account teams

Fitch upgrades viability rating for PNB and Union Bank of India

Both showed improved risk profile with better financial performance

Pfizer's breast cancer drug Vepdegestrant posts mixed results in key trial

The drug, vepdegestrant, failed to meaningfully delay cancer progression for all patients enrolled in the study but met its goals for a subset who have a specific genetic mutation